Biogen insider trading
Health Care · Net sellingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 0 Biogen insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $905K. 4 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 74 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 5SEC | Lloyd MinorDirector | Sell Plan | 593 | $203.34 | $121K | +10.0% | — |
| Aug 5SEC | Lloyd MinorDirector | Sell Plan | 593 | $200.96 | $119K | +11.3% | — |
| Feb 17SEC | Nicole MurphyHead Of Pharm Ops And Tech | Buy | 3 | $195.03 | $585 | +14.6% | — |
| Feb 10SEC | Priya SinghalHead Of Development | Sell Plan | 2,660 | $199.83 | $532K | +11.9% | — |
| Feb 3SEC | Priya SinghalHead Of Development | Sell Plan | 748 | $179.30 | $134K | +24.7% | — |
Insiders at Biogen
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Priya SinghalHead Of Development | — | $666K | Feb 10, 2026 | — |
| Lloyd MinorDirector | — | $240K | Aug 5, 2026 | — |
| Nicole MurphyHead Of Pharm Ops And Tech | $585 | — | Feb 17, 2026 | — |
| Maria C FreireDirector | — | — | Jun 11, 2026 | — |
| Menelas N PangalosDirector | — | — | Jun 11, 2026 | — |
| Monish D PatolawalaDirector | — | — | Jun 11, 2026 | — |
| Susan LangerDirector | — | — | Jun 11, 2026 | — |
| Jesus B MantasDirector | — | — | Jun 11, 2026 | — |
| Eric K RowinskyDirector | — | — | Jun 11, 2026 | — |
| Stephen A SherwinDirector | — | — | Jun 11, 2026 | — |
| William A HawkinsDirector | — | — | Jun 11, 2026 | — |
| Adam KeeneyHead Of Corporate Development | — | — | May 5, 2026 | — |
| Sean GodboutChief Accounting Officer | — | — | Apr 3, 2026 | — |
| Christopher ViehbacherCEO, President | — | — | Feb 10, 2026 | — |
| Susan H AlexanderGeneral Counsel | — | — | Feb 10, 2026 | — |
| Ginger GregoryEvp, Human Resources | — | — | Feb 10, 2026 | — |
| Robin KramerCFO | — | — | Feb 10, 2026 | — |
| Rachid IzzarHead Of Global Product Strat. | — | — | Feb 10, 2026 | — |
| Jane GroganHead Of Research | — | — | Feb 10, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about BIIB insiders
Are Biogen insiders buying BIIB stock?
In the past 12 months, 0 insiders reported open-market purchases of BIIB worth $0. The latest was Head Of Pharm Ops And Tech Nicole Murphy bought $585 of BIIB at $195.03 — first open-market purchase in our records.
Are Biogen insiders selling BIIB stock?
2 insiders reported sales worth $905K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.